key: cord-0838508-oltbv84g authors: Wee, Liang E.; Tan, Jing Y.; Chung, Shimin J.; Conceicao, Edwin P.; Hock Tan, Ban; Venkatachalam, Indumathi title: Zero health‐care‐associated respiratory viral infections among solid organ transplant recipients: Infection prevention outcomes during COVID‐19 pandemic date: 2021-02-17 journal: Am J Transplant DOI: 10.1111/ajt.16499 sha: b5713dc582a9aadf65feacce05b83d45e6823b15 doc_id: 838508 cord_uid: oltbv84g We read with interest the paper by Coll et al. that reported a mortality rate of 27% in a large series of transplant recipients with concurrent COVID-19; with nosocomial acquisition in 13% of cases.1 Outside the pandemic setting, however, solid-organ-transplant (SOT) recipients are more likely to experience prolonged and severe illness from common respiratory-viral-infections (RVIs), and healthcare-associated-RVI (HA-RVI) is a significant issue. The impetus for implementation of aggressive infection-prevention measures against COVID-19 on transplant units may reduce HA-RVI as a positive consequence. To the Editor: We read with interest the paper by Coll COVID-19 in transplant recipients: the Spanish experience Respiratory viruses in transplant recipients: more than just a cold. Clinical syndromes and infection prevention principles Respiratory surveillance wards as a strategy to reduce nosocomial transmission of COVID-19 through early detection: the experience of a tertiary-care hospital in Singapore Public health measures during COVID-19 pandemic reduced hospital admissions for community respiratory viral infections Practical considerations for solid organ transplantation during the COVID-19 global outbreak: the experience from Singapore